CRISPR Therapeutics AG CRSP
$ 50.68
-0.17%
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q2
добавлен 05.08.2024
CRISPR Therapeutics AG Мультипликаторы 2011-2024 | CRSP
Мультипликаторы по годам CRISPR Therapeutics AG
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-42.3 | -5.6 | 15.2 | -28.9 | 42.6 | -9.4 | -24.4 | -9.4 | - | - | - | - | - |
P/S |
17.5 | 3041.7 | 6.3 | 14043.9 | 9.8 | 495.0 | 40.7 | 42.1 | - | - | - | - | - |
EPS |
-1.9 | -8.4 | 5.0 | -5.3 | 1.2 | -3.4 | -1.7 | -1.9 | -5.1 | 2.0 | - | - | - |
EV (Enterprise Value) |
6.45 млрд | 3.8 млрд | 5.18 млрд | 9.09 млрд | 2.03 млрд | 1.19 млрд | 1.51 млрд | 14 млн | 32.6 млн | 7.56 млн | - | - | - |
EBITDA per Share |
-2.56 | -8.35 | 5.15 | -5.24 | 0.946 | -3.24 | -1.54 | -5.48 | - | - | - | - | - |
EV/EBITDA |
13.1 | -30.4 | 37.1 | -7.0 | -23.2 | 1.5 | - | - | - | - | - | ||
PEG |
0.16 | 0.02 | -0.08 | 0.05 | 0.31 | 0.09 | -2.57 | 0.19 | - | - | - | - | - |
P/B |
3.5 | 1.9 | 2.4 | 6.1 | 3.0 | 3.9 | 8.9 | 0.9 | - | - | - | - | - |
P/CF |
-24.9 | -7.4 | 10.7 | -42.4 | 57.0 | -15.6 | -21.4 | -3.7 | - | - | - | - | - |
ROE % |
-8.16 | -34.67 | 15.74 | -20.96 | 7.12 | -42.07 | -36.39 | -9.96 | - | - | - | - | - |
ROA % |
-6.89 | -28.99 | 13.72 | -19.08 | 6.27 | -33.74 | -25.19 | -6.73 | - | - | - | - | - |
ROCE % |
-11.82 | -35.89 | 15.57 | -21.30 | 4.63 | -34.46 | -25.17 | -21.10 | - | - | - | - | - |
Current Ratio |
6.4 | 6.1 | 7.8 | 11.2 | 17.3 | 16.8 | 17.1 | 14.6 | - | - | - | - | - |
DSO |
- | - | 0.1 | 61.7 | 0.1 | 10.3 | 23.4 | 223.1 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | 0.1 | 61.7 | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | 0.1 | 61.7 | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально CRISPR Therapeutics AG
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.49 | -1.43 | - | -1.41 | -0.98 | -0.67 | - | -2.24 | -2.4 | -2.32 | - | -1.67 | 10.01 | -1.51 | -1.5 | -1.32 | -1.3 | -1.15 | 0.53 | 2.52 | -1.01 | -0.93 | -0.92 | -1.07 | -0.82 | -0.62 | - | -0.62 | -0.56 | -0.54 | 0.43 | -2.77 | -3.15 | -1.53 | -2.22 | -1.15 | -0.8 | -0.91 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-1.72 | -1.66 | - | -1.61 | -1.14 | -0.76 | - | -2.27 | -2.27 | -2.2 | - | -1.54 | 10.1 | -1.49 | -1.51 | -1.22 | -1.24 | -1.17 | 0.19 | 2.6 | -1 | -0.91 | -0.88 | -0.99 | -0.76 | -0.57 | 0.02 | -0.53 | -0.5 | -0.5 | -0.77 | -2.66 | -2.99 | -2.09 | -2.2 | -1.11 | -0.8 | -1.05 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-24.96 | -22.86 | -13.63 | -22.57 | -25.01 | -29.62 | -25.80 | -30.86 | -26.99 | 11.06 | 17.83 | 11.40 | 10.90 | -23.04 | -20.96 | -11.28 | 9.01 | 8.08 | 7.12 | -8.27 | -35.93 | -40.00 | -42.07 | -29.86 | -30.08 | -32.18 | -36.39 | -29.12 | -22.27 | -17.76 | -9.95 | 24.87 | 53.01 | 60.38 | 64.00 | 21.83 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-20.93 | -19.07 | -11.28 | -18.69 | -20.74 | -24.74 | -21.84 | -26.34 | -23.43 | 10.30 | 15.90 | 10.04 | 9.49 | -21.05 | -19.08 | -10.37 | 7.67 | 6.99 | 6.27 | -6.33 | -29.67 | -32.49 | -33.74 | -23.95 | -22.69 | -23.06 | -25.19 | -20.29 | -15.44 | -12.19 | -6.72 | -19.37 | -19.10 | -14.13 | -11.68 | -3.98 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-29.71 | -27.32 | -16.38 | -25.72 | -27.39 | -30.91 | -25.94 | -31.07 | -26.86 | 11.20 | 17.82 | 11.34 | 10.92 | -23.22 | -21.30 | -13.65 | 6.71 | 5.71 | 4.98 | -7.73 | -35.14 | -38.80 | -40.53 | -28.48 | -28.42 | -30.26 | -34.42 | -45.81 | -39.53 | -35.30 | -29.26 | 23.42 | 51.01 | 58.12 | 63.13 | 21.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
6.5 | 6.9 | 6.4 | 5.8 | 5.8 | 5.8 | 6.1 | 5.9 | 6.6 | 7.2 | 7.8 | 9.1 | 9.8 | 12.8 | 11.2 | 11.2 | 11.2 | 11.2 | 8.4 | 8.4 | 8.4 | 8.4 | 5.0 | 5.0 | 5.0 | 5.0 | 3.2 | 3.2 | 3.2 | 3.2 | 3.1 | 3.1 | 3.1 | 3.1 | 1.3 | 1.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | 55.8 | 60.4 | 21.7 | - | 16.7 | 0.0 | 24.9 | 35.5 | 88.8 | 298.6 | 70.6 | 0.1 | 0.0 | 28.4 | 26.0 | 69.8 | 14.3 | 7.4 | 91.2 | 7.4 | 100.4 | 66.9 | 97.6 | 122.9 | 186.0 | 362.4 | 335.1 | 125.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | 55.8 | 60.4 | 21.7 | - | 16.7 | 0.0 | 24.9 | 35.5 | 88.8 | 298.6 | 70.6 | 0.1 | 0.0 | 28.4 | 26.0 | 69.8 | 14.3 | 7.4 | 91.2 | 7.4 | 100.4 | 66.9 | 97.6 | 122.9 | 186.0 | 362.4 | 335.1 | 125.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | 55.8 | 60.4 | 21.7 | - | 16.7 | 0.0 | 24.9 | 35.5 | 88.8 | 298.6 | 70.6 | 0.1 | 0.0 | 28.4 | 26.0 | 69.8 | 14.3 | 7.4 | 91.2 | 7.4 | 100.4 | 66.9 | 97.6 | 122.9 | 186.0 | 362.4 | 335.1 | 125.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD